Biogen’s R&D head Douglas Williams jumps ship for a new startup
As is the case with many big biopharma execs, Biogen's R&D head Douglas Williams is leaving to launch an as-yet-unnamed new cancer diagnostics or therapeutics startup, Biogen says.
As is the case with many big biopharma execs, Biogen's R&D head Douglas Williams is leaving to launch an as-yet-unnamed new cancer diagnostics or therapeutics startup, Biogen says.